Cargando…

Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities

INTRODUCTION: A growing population of adults living with severe, chronic childhood-onset health conditions has created a need for specialized health care delivered by providers who have expertise both in adult medicine and in those conditions. Optimal care of these patients requires systematic appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanzkron, Sophie, Sawicki, Gregory S., Hassell, Kathryn L., Konstan, Michael W., Liem, Robert I., McColley, Susanna A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390387/ https://www.ncbi.nlm.nih.gov/pubmed/30828476 http://dx.doi.org/10.1017/cts.2018.338

Ejemplares similares

Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights
por: Ideozu, Justin E., et al.
Publicado: (2019)

Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
por: Ideozu, Justin E., et al.
Publicado: (2019)

Antibiotic duration and changes in FEV(1) are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
por: Espel, Julia C., et al.
Publicado: (2017)

2206 Chicago Kids Advisory Board: A novel approach to engaging adolescent students in pediatric clinical research
por: Hebal, Ferdynand, et al.
Publicado: (2018)

COVID-19 outcomes in sickle cell disease and sickle cell trait
por: Christian, Jana, et al.
Publicado: (2022)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States
por: Sontag, Marci K., et al.
Publicado: (2022)

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR
por: Rayment, Jonathan H., et al.
Publicado: (2022)

Current Evidence and Rationale to Guide Perioperative Management, Including Transfusion Decisions, in Patients With Sickle Cell Disease
por: Azbell, Roberta C. G., et al.
Publicado: (2023)

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
por: Bessonova, Leona, et al.
Publicado: (2018)

Preclinical testing of antimicrobials for cystic fibrosis lung infections: current needs and future priorities
por: Hubert, Lucile, et al.
Publicado: (2023)

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
por: Bishay, Lara C, et al.
Publicado: (2016)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Health Care Utilization by Adolescent/Young Adult Patients With Sickle Cell Disease in Delaware
por: Guarino, Stephanie, et al.
Publicado: (2022)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

A refresh of the top 10 research priorities in cystic fibrosis
por: Rowbotham, Nicola Jane, et al.
Publicado: (2023)

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation
por: Sawicki, Gregory S., et al.
Publicado: (2022)

Best practices for transfusion for patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2010)

The Telemedicine Experience for Individuals with Sickle Cell Disease
por: Weiss, Sara, et al.
Publicado: (2021)

Author Reply to: Empowering Without Misinforming Adolescents and Young Adults with Cystic Fibrosis. Comment on “Perceptions of Social Media Use to Augment Health Care Among Adolescents and Young Adults With Cystic Fibrosis: Survey Study”
por: Perkins, Ryan C, et al.
Publicado: (2022)

Most Short Children with Cystic Fibrosis Do Not Catch Up by Adulthood
por: Marks, Margaret P., et al.
Publicado: (2021)

Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials
por: VanDevanter, Donald R., et al.
Publicado: (2021)

Peer Mediated Groups:: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2022)

Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report
por: Ruhl, A. Parker, et al.
Publicado: (2019)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
por: VanDevanter, Donald R, et al.
Publicado: (2010)

Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future()
por: Sawicki, Gregory S., et al.
Publicado: (2021)

Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
por: Lubeck, Deborah, et al.
Publicado: (2019)

In transition: current health challenges and priorities in Sudan
por: Charani, Esmita, et al.
Publicado: (2019)

Monogenic Diabetes in a Child with Cystic Fibrosis: A Case Report and Review of the Literature
por: Scully, Kevin J, et al.
Publicado: (2020)

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs()
por: Gifford, Alex H., et al.
Publicado: (2021)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Developmental disorders in children born to women with sickle cell disease: A report from the Boston Birth Cohort
por: Brucato, Martha, et al.
Publicado: (2022)

Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018
por: Early, Macy L., et al.
Publicado: (2023)

A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
por: Lee, LaTasha H., et al.
Publicado: (2021)

Family planning needs of young adults with sickle cell disease
por: Linton, Elizabeth A., et al.
Publicado: (2023)

Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder
por: Greenberg, Jonathan, et al.
Publicado: (2016)

Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
por: Putman, Melissa S., et al.
Publicado: (2023)

Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
por: Putman, Melissa S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qik21r4ocj1jqg8r3rvnrer9hb